ViQi Inc

At ViQi we’ve embraced predictive AI as the next step in the natural evolution of using software to drive progress. We’re not interested in replacing humans and their creative, novel thinking with AI; rather, we want to make the impossible possible. In the past several decades people have mastered generating data using computers built into every tool we use in our daily lives whether that be in our jobs, at our homes with our families, or going out for a night on the town. But what do we do with all of that data? Engineers, scientists, and business leaders are getting better at defining metrics and goals and then using the data to monitor the path to achieving those goals. But we’re now producing far more data than we can meaningfully use even with the tools and capabilities we developed over the last several years. Until now. This is where predictive AI comes in. Eric Siegel wrote this great article (https://lnkd.in/gPi9cuXp) for Forbes describing the difference between generative and predictive AI, pointing out the value of predictive AI. This aligns with how the team at ViQi is thinking about this space. Checkout what we’re doing at ViQi (viqiai.com) to advance scientific answers using predictive AI technology.

At ViQi we’ve embraced predictive AI as the next step in the natural evolution of using software to drive progress. We’re not interested in replacing humans and their creative, novel thinking with AI; rather, we want to make the impossible possible. In the past several decades people have mastered generating data using computers built into every tool we use in our daily lives whether that be in our jobs, at our homes with our families, or going out for a night on the town. But what do we do with all of that data? Engineers, scientists, and business leaders are getting better at defining metrics and goals and then using the data to monitor the path to achieving those goals. But we’re now producing far more data than we can meaningfully use even with the tools and capabilities we developed over the last several years. Until now. This is where predictive AI comes in. Eric Siegel wrote this great article (https://lnkd.in/gPi9cuXp) for Forbes describing the difference between generative and predictive AI, pointing out the value of predictive AI. This aligns with how the team at ViQi is thinking about this space. Checkout what we’re doing at ViQi (viqiai.com) to advance scientific answers using predictive AI technology.

We are excited to announce that Dr. Tong-Ming Fu M.D., Ph.D. (Tong-Ming Fu) has joined the ViQi Scientific Advisory Board. His expertise in virology and his experience with the ViQi flagship AI-based Automated Viral Infectivity Assay (AVIA™) will be instrumental in our continued mission to leverage computational technology to gain insights from image-based data See the press release here! https://lnkd.in/gtRVEdmv #virologyassays #highcontentimaging #AVIA

ViQi's Chief Science Officer, Ilya Goldberg, presented at the Bio International Convention this week!

Mark your calendars! Our Chief Science Officer, Dr. Ilya Goldberg, will be presenting at the BIO International Convention in San Diego next week. He'll be sharing insights on "Predictive AI for Bioprocess Optimization" during the "Capabilities for Advanced Biomanufacturing" session. Don't miss this chance to hear from industry experts on enhancing opportunities and meeting challenges for global access in biomanufacturing. Join us on Monday, June 3rd from 3-4pm at the BioProcess Theater in Hall H. #BIOInternational2024 #Biomanufacturing #AI

Loving the energy and excitement around the innovations being shown at #ASGCT2024! We're proud to be showcasing our advancements in gene and cell therapy through our AutoHCS analysis toolkit. These #AIs can enable you to automatically score cell state in IPSCs (induced pluripotent stem cells), identify cytotoxicity, and much much more. -- Visit Booth #1957 to learn more!

We're having a fantastic day here at #ASGCT2024! We’ve met so many inspiring researchers already and have enjoyed answering questions about our cloud-based and scalable #infectivityassay for characterization of viral gene therapy vectors - if you're attending, come on by Booth #1957 to keep the conversation going!

Are you attending the #ASGCT2024 Annual Meeting in Baltimore next week? Make sure to stop by booth #1957 to meet our team and learn about AVIA, our groundbreaking AI-based viral infectivity assay. We'll be showcasing how AVIA can streamline your viral titer quantification process, eliminating the need for laborious #plaqueassays and #TCID50s. Don't miss this opportunity to add a great AI solution to streamline your lab workflows!

Tired of running labor intensive plaque assays? Visit us at booth #1957 during the #ASGCT2024 Annual Meeting (May 7-11) in Baltimore to learn about our #AI-based viral #infectivityassay, AVIA. This cutting-edge solution streamlines viral titer quantification, providing answers in days not weeks. Stop by to discover how AVIA can meaningfully transform your day-to-day lab operations!